Proteotech, a SME created in 2006 in the Science Park of Sardinia (Cagliari, Italy), has assembled a team of researchers in the biochemistry, microbiology and immunology fields, with particular focus on proteomics applied to biomedical applications, food safety and security and to animal models for human health.
Proteotech is a unique platform in proteomics focused on research and development of biomarker discovery in the field of microorganisms, zoonosis and immune-mediated diseases.
The Company has its headquarter and labs in the Science Park, and it has strong collaborations with other institutions, mainly University of Milan and Istituto Sperimentale Italiano Lazzaro Spallanzani. Several researchers of University and CNR work in contact with the Company’s lab.
Attività e Servizi
Proteotech offers solutions in this field developing a potent proteomic platform for biomarker discovery study, and offers a wide set of technologies useful to the development of products in proteomic analysis.
The key elements of the business strategies include:
9010 proteins biomarker discovery
9011 high throughput technologies for proteomic analysis
9012 new protein separation technologies
9013 vaccine developments.
9014 Bacteria to identify new antimicrobial targets.